Estrogen receptor α and hedgehog signal pathway developmental biology of gastric adenocarcinoma

Hepato-Gastroenterology

Volumn 59, Issue 116, 2012, Pages 1319-1322

  Xu, Chaoyang ^a   Li, Jiajia ^a   Lu, Yangyang ^b   Jiang, Zhinong ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Estrogen receptor ; Gastric adenocarcinoma; Hedgehog

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SONIC HEDGEHOG PROTEIN;

CELL PROLIFERATION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ANIMALS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; HEDGEHOG PROTEINS; HUMANS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84861391099     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11549     Document Type: Review

References (52)

1. Yonemura Y, Endou Y, Sasaki T, et al.: Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol 2010; 36:1131-1138.
2. Bartlett JM, Ellis IO, Dowsett M, et al.: Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy. J Clin Oncol 2007; 25:4423-4430.
3. Zhu f, Xu C, Jiang Z, et al.: Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Anat Rec (Hoboken) 2010; 293:1310-1314.
4. Low JS, Tao Q, Ng KM, et al.: A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene 2011; 30:1923-1935.
5. Song G, Zeng H, Li J, et al.: miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. Biol Pharm Bull 2010; 33:1822-1827.
6. Tsang YH, Lamb A, Romero-Gallo J, et al.: Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 2010; 29:5643-5650.
7. Lee MS, Cha EY, Thuong PT, et al.: Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells. Biol Pharm Bull 2010; 33:931-937.
8. Mai W, Kawakami K, Shakoori A, et al.: Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase. Clin Cancer Res 2009; 15:6810-6819.
9. Yasumoto K, Yamada T, Kawashima A, et al.: The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Clin Cancer Res 2011; 17:3619-3630.
10. Kim KC, Koh YW, Chang HM, et al.: Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. Clin Cancer Res 2010; 16:1509-1519.
11. Holden J, Garrett Z, Stevens A: NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer. Lancet Oncol 2011; 12:16-17.
12. Bang YJ, Van Cutsem E, feyereislova A, et al.: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376:687-697.
13. Mitsuno M, Kitajima Y, Ide T, et al.: Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. J Gastroenterol 2007; 42:866-873.
14. Wang M, Pan JY, Song GR, et al.: Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Eur J Surg Oncol 2007; 33:195-201.
15. foryst-Ludwig A, Kintscher U: Metabolic impact of estrogen signaling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 2010; 122:74-81.
16. Tokunaga A, Nishi K, Matsukura N, et al.: Estrogen and progesterone receptors in gastric cancer. Cancer 1986; 57:1376-1379.
17. Clemens LE, Shih YH, Brink HO, et al.: Physiologic significance of 17beta-estradiol binding in the rabbit Fallopian tube. Am J Obstet Gynecol 1975; 122:113-122.
18. May fE, Westley BR: Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res 1986; 46:6034-6040.
19. La Rosa P, Pesiri V, Marino M et al.: 17β-Estradiol-induced cell proliferation requires estrogen receptor (ER) α mono-ubiquitination. Cell Signal 2011; 23:1128-1135.
20. Suzuki A, Sanda N, Miyawaki Y, et al.: Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem 2010; 285:13444-13453.
21. Pedraza-Alva G, Zingg JM, Donda A, et al.: Estrogen receptor regulates MyoD gene expression by preventing AP-1-mediated repression. Biochem Biophys Res Commun 2009; 389:360-365.
22. frasor J, Weaver A, Pradhan M, et al.: Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res 2009; 69:8918-8925.
23. Wang X, Belguise K, O'Neill Cf, et al.: NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Mol Cell Biol 2009; 29:3832-3844.
24. Díaz-Cruz ES, furth PA: Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res 2010; 70:3965-3974.
25. Pearl CA, Berger T, Roser Jf: Estrogen and androgen receptor expression in relation to steroid concentrations in the adult boar epididymis. Domest Anim Endocrinol 2007; 33:451-459.
26. Oliveira AG, Dornas RA, Mahecha GA, et al.: Occurrence and cellular distribution of estrogen receptors ERα and ERβ in the testis and epididymal region of roosters. Gen Comp Endocrinol 2011; 170:597-603.
27. Defino MC, Wacker JL, Lyssand JS, et al.: Differential regulation of GPR54 transcription by specificity protein-1 and partial estrogen response element in mouse pituitary cells. Biochem Biophys Res Commun 2010; 393:603-608.
28. Wang A, Ji L, Shang W, et al.: Expression of GPR30, ERα and ERβ in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study. Gynecol Endocrinol 2011; 27:251-255.
29. Nothnick WB, Healy C: Estrogen induces distinct patterns of microRNA expression within the mouse uterus. Reprod Sci 2010; 17:987-994.
30. Lane PH: Estrogen receptors in the kidney: lessons from genetically altered mice. Gend Med 2008; 5:S11-8.
31. Weiser MJ, Handa RJ: Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009; 159:883-895.
32. Parés D, Iglesias M, Pera M, et al.: Expression of estrogen and progesterone receptors in the anal canal of women according to age and menopause. Dis Colon Rectum 2010; 53:1687-1691.
33. Miró AM, Sastre-Serra J, Pons DG, et al.: 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 2011; 123:133-139.
34. Kontos S, Kominea A, Melachrinou M, et al.: Inverse expression of estrogen receptor-beta and nuclear factor-kappa B in urinary bladder carcinogenesis. Int J Urol 2010; 17:801-809.
35. Miceli V, Cocciadiferro L, fregapane M, et al.: Expression of wild-type and variant estrogen receptor alpha in liver carcino-genesis and tumor progression. OMICS 2011; 15:313-317.
36. Massarweh S, Schiff R: Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. Endocr Relat Cancer 2006; 13:S15-24.
37. Olivo-Marston SE, Mechanic LE, Mollerup S, et al.: Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis 2010; 31:1778-1786.
38. Oshima CT, Wonraht DR, Catarino RM, et al.: Estrogen and progesterone receptors in gastric and colorectal cancer. Hepato-gastroenterol 1999; 46:3155-3158.
39. Xu CY, Guo JL, Jiang ZN, et al.: Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol 2010; 17:2503-2509.
40. Siegfried JM, Hershberger PA, Stabile LP: Estrogen receptor signaling in lung cancer. Semin Oncol 2009; 36:524-531.
41. Chen J, Liu L, Hou R et al.: Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Lett 2011; 308:144-151.
42. Pfaffl MW, Lange IG, Meyer HH: The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR. J Steroid Biochem Mol Biol 2003; 84:159-166.
43. Chandanos E, Lagergren J: Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer 2008; 44:2397-2403.
44. Takano N, Iizuka N, Hazama S, et al.: Expression of estrogen receptor-alpha and -beta mRNAs in human gastric cancer. Cancer Lett 2002; 176:129-135.
45. Kameda C, Nakamura M, Tanaka H, et al.: Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. Br J Cancer 2010; 102:738-747.
46. Dubik D, Shiu RP: Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 1992; 7:1587-1594.
47. Barros R, Camilo V, Pereira B, et al.: Pathophysiology of intestinal metaplasia of the stomach: emphasis on CDX2 regulation. Biochem Soc Trans 2010; 38:358-363.
48. Ito M, Takata S, Tatsugami M, et al.: Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009; 44:365-371.
49. El-Zaatari M, Saqui-Salces M, Waghray M, et al.: Sonic hedgehog in gastric physiology and neoplastic transformation: friend or foe? Curr Opin Endocrinol Diabetes Obes 2009; 16:60-65.
50. Mimata A, fukamachi H, Eishi Y, et al.: Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 2011; 102:942-950.
51. Heretsch P, Tzagkaroulaki L, Giannis A: Modulators of the hedgehog signaling pathway. Bioorg Med Chem 2010; 16:337-348.
52. Barakat MT, Humke EW, Scott MP: Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med 2010; 16:337-348.